MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSITION SUMMARY
The Associate Director, International Commercial Supply Planning is responsible for leading Mirum’s commercial finished goods supply planning, packaging operations, CPO management, serialization and artwork management processes across international markets. This role ensures uninterrupted, compliant product supply by orchestrating end-to-end planning activities and partnering closely with CMC, Regulatory, Quality, Global Commercial Supply Chain, and external packaging partners. This person will drive continuous improvement, support new product introductions, manage complex jurisdictional requirements, and maintain robust operating processes and systems. This position requires a strategic yet hands-on leader who can thrive in a dynamic environment while maintaining strong cross-functional collaboration and operational excellence.
JOB FUNCTIONS/RESPONSIBILITIES
Supply Planning & CPO Management
- Own the end-to-end international commercial supply planning and packaging process, including management of Mirum’s CPOs and oversight of raw material (Drug Product) allocation based on jurisdictional control requirements.
- Develop and execute packaging plans that ensure uninterrupted product supply, proactively managing replenishments to support global forecasts while optimizing inventory and communicating supply risks and needs across Mirum and CPO partners.
- Manage POs and budget expenses for CPO partners
- Manage logistics flows from CPOs to 3PLs to ensure compliant, timely, and cost-effective distribution.
Artwork, Labeling & Serialization Management
- Lead the international artwork management process, ensuring timely development of compliant artwork aligned with global labeling and worldwide regulatory requirements.
- Partner with Global Labeling and cross-functional teams on regulatory submissions, labeling updates, and product-specific initiatives.
- Oversee serialization requirements for all relevant markets, ensuring accurate generation, application, verification, and data exchange of serialized codes in compliance with global regulations (e.g., EU FMD, DSCSA, and other regional mandates).
- Support labeling, serialization, and packaging inspection/audit-readiness activities.
Cross-Functional Collaboration & Process Ownership
- Partner with Global Commercial Supply Chain team to continuously optimize S&OP and Global Supply Review (GSR) processes—ensuring no interruptions to international supply while managing allocation and packaging operations.
- Collaborate closely with CMC, Regulatory, and Quality to ensure seamless transition from process validation to commercial packaging; ensure technical requirements are incorporated into routine packaging activities.
- Work with the Supply Chain Ops BPO to establish and maintain commercial supply chain systems and master data, including Kinaxis Maestro® Advanced Planning System.
- Partner with the Supply Chain Ops BPO to draft, implement, and maintain SOPs related to packaging, jurisdictional control, planning, and artwork management.
- Provide cross-functional supply chain support by serving as a backup for other Supply Chain team members when needed, ensuring continuity of operations during peak demand, absence, or critical business needs.
Continuous Improvement & Project Leadership
- Lead and/or participate in supply chain projects and initiatives related to serialization, artwork, packaging, and distribution to enhance supply flow, reduce inventory costs, and improve business processes.
- Support new product introductions and lifecycle management initiatives.
- Maintain awareness of evolving regulatory requirements that may impact Mirum’s end-to-end supply chain.
QUALIFICATIONS
Education/Experience
- A./B.S. required.
- 7+ years of global supply chain or supply planning experience (including S&OP) within pharmaceutical or biotech operations.
- Experience working with CPOs, 3PLs, vendors, and in serialization and artwork management.
- Strong understanding of labeling and serialization processes and requirements (including cold chain) and trade compliance.
- Experience across end-to-end supply chain processes: forecasting, inventory management, safety stock strategies, jurisdictional control, and artwork/labeling.
- Advanced Planning System experience required (Kinaxis Maestro® strongly preferred).
- APICS, CSCP, or CPIM certification preferred.
- Demonstrated project management, negotiation, cross-functional communication, and/or new product supply chain planning skills.
PREFERRED QUALIFICATIONS
- Proven ability to manage end-to-end supply planning in a virtual manufacturing environment with CPOs, logistics partners, and 3PLs.
- Agile, proactive mindset with strong judgment and the ability to make decisions in ambiguous situations.
- Strong understanding of labeling, serialization processes and requirements, and regulatory expectations supporting global labeling strategies.
- Ability to work independently and drive decisions proactively
- Ability to manage complex product allocations to meet jurisdictional needs.
- Demonstrated ability to build strong partnerships with CPOs, suppliers, and internal teams.
- Excellent communication, organization, and attention to detail.
- Creative problem-solver with the ability to prioritize, re-prioritize, and multi-task in a dynamic environment.
- Willingness to challenge the status quo, propose improvements, and “roll up sleeves” as needed.
- High integrity, team-oriented, dependable, and committed to operational excellence.
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
Mirum Pharmaceuticals Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Mirum Pharmaceuticals and has not been reviewed or approved by Mirum Pharmaceuticals.
-
Equity Value & Accessibility — Equity grants to new hires and an employee stock purchase plan make ownership more accessible and can boost total rewards when performance is strong. Public disclosures highlight frequent option/RSU inducements.
-
Healthcare Strength — Comprehensive medical, dental, and vision coverage is employer-paid for employees, with added life, disability, and EAP support. This combination reduces financial burden and enhances overall wellbeing.
-
Leave & Time Off Breadth — A broad time-off program includes multiple paid company holidays, a year-end shutdown, accrued vacation, and paid parental leave. This breadth provides additional rest periods beyond standard vacation.
Mirum Pharmaceuticals Insights
Similar Jobs
What We Do
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older. Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. Maralixibat (LIVMARLI), an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 study for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK Phase 2b study for patients with biliary atresia. In addition, Mirum has an expanded access program open in Canada, Australia, the UK and several countries in Europe for eligible patients with Alagille syndrome. Mirum has submitted a Marketing Authorization Application to the European Medicines Agency for maralixibat for the treatment of cholestatic liver disease in patients with Alagille syndrome. Mirum’s second investigational treatment, volixibat, also an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the OHANA Phase 2b study for pregnant women with intrahepatic cholestasis of pregnancy, VISTAS Phase 2b study for adults with primary sclerosing cholangitis, and the VANTAGE Phase 2b study for primary biliary cholangitis.







